Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences
Abstract Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) provided high-quality evidence, the real-world evidence is still needed. This systematic review and meta-analysis pr...
Main Authors: | Yoga Waranugraha, Ardian Rizal, Mokhamad Fahmi Rizki Syaban, Icha Farihah Deniyati Faratisha, Nabila Erina Erwan, Khadijah Cahya Yunita |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-08-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43044-021-00194-1 |
Similar Items
-
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
by: Faye L. Norby, et al.
Published: (2017-09-01) -
Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01) -
Pregnancy and non-valvular heart disease - Anesthetic considerations
by: Maitra Gaurab, et al.
Published: (2010-01-01) -
Is There Association Between Changes in eGFR Value and the Risk of Permanent Type of Atrial Fibrillation? - Analysis of Valvular and Non-Valvular Atrial Fibrillation Population
by: Elzbieta Mlodawska, et al.
Published: (2014-12-01) -
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population
by: Kiran Gupta, et al.
Published: (2019-06-01)